A laboratory result is only as reliable as the sample on which it is based – an M&A deal only as valuable as its integration. The testing and diagnostic laboratory market is in a fever of consolidation: more than 1,400 acquisitions between 2015 and 2025 alone, but 70 to 90 percent of all transactions fail to achieve their synergy goals. Deviating SOPs, a "LIMS-zoo" of historically grown IT systems, regulatory pitfalls with ISO 17025 and ISO 1518…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
A laboratory result is only as reliable as the sample on which it is based – an M&A deal only as valuable as its integration. The testing and diagnostic laboratory market is in a fever of consolidation: more than 1,400 acquisitions between 2015 and 2025 alone, but 70 to 90 percent of all transactions fail to achieve their synergy goals. Deviating SOPs, a "LIMS-zoo" of historically grown IT systems, regulatory pitfalls with ISO 17025 and ISO 1518…